The Use of Serum Hcg As a Marker of Tumor Progression and of the Response of Metastatic Urothelial Cancer to Systemic Chemotherapy.

Karen A. Malkhasyan,Hari A. Deshpande,Adebowale Adeniran,John W. Colberg,Daniel P. Petrylak

PubMed（2013）

引用 25|浏览0

暂无评分

摘要

This case confirms the observation that urothelial carcinomas can secrete beta-hCG, and that beta-hCG can potentially be used as a marker of a patient's clinical response to treatment. Prospective studies are clearly warranted by these observations.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要